Technical guides and protocols for lateral flow assays.
A side-by-side technical comparison of RAA, RPA, LAMP, and PCR amplification methods, with an actionable selection guide for IVD distributors and POCT developers.
CRISPR-based diagnostics are attracting strong interest in molecular point-of-care testing because they combine sequence-specific recognition with simple signal readout. Cas12 and Cas13 systems are especially useful for nucleic acid detection. Cas12 is commonly associated with DNA target detection, while Cas13 is widely used for RNA target detection. When combined with lateral flow strips, these systems … Read more
Lateral flow assay manufacturing looks simple from the outside, but consistent performance depends on many tightly controlled process parameters. For POCT test strips, small changes in membrane lots, conjugate drying, dispensing volume, cutting width, humidity, and assembly pressure can affect sensitivity, background, flow time, and reproducibility. A stable manufacturing process is therefore essential for both … Read more
Global IVD distributors are no longer only looking for finished products. Many are building differentiated portfolios through OEM and ODM cooperation. In point-of-care testing, this approach allows distributors to combine local market knowledge with manufacturer capabilities in assay development, instrument design, packaging, documentation, and regulatory support. Why OEM and ODM matter in POCT POCT markets … Read more
Time-resolved fluorescence immunoassay, often abbreviated as TRFIA, is becoming an important platform for point-of-care testing because it combines the workflow simplicity of immunoassay with improved analytical sensitivity. For IVD manufacturers, distributors, and clinical laboratories, the main value of a TRF immunoassay analyzer is not only a stronger signal. It is the ability to separate useful … Read more
Microfluidic PCR systems are reshaping molecular diagnostics by reducing reaction volume, improving heat transfer, and enabling faster amplification in compact instruments. For decentralized testing environments such as clinics, emergency departments, field laboratories, and regional diagnostic centers, microfluidic PCR provides a practical route to molecular-level sensitivity without relying entirely on centralized laboratories. Why microfluidics accelerates PCR … Read more
The Convergence of AI and Point-of-Care Testing The global point-of-care diagnostics market is projected to reach USD 98.6 billion by 2034, growing at a remarkable 9.9% CAGR. At the heart of this expansion lies a transformative force: artificial intelligence. AI is no longer a futuristic concept in diagnostics—it is actively reshaping how clinicians interpret results, … Read more
/tmp/content_crispr-based-diagnostics-next-generation-poct-molecular-testing.html
/tmp/content_microfluidic-pcr-vs-traditional-pcr-technical-comparison-ivd-professionals.html
/tmp/content_point-of-care-testing-revolution-2026-poct-transforming-global-healthcare.html